SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001829126-24-001064
Filing Date
2024-02-22
Accepted
2024-02-22 14:26:36
Documents
1
Group Members
LEEN KAWASPROPEL BIO PARTNERS LLCRICHARD KAYNERICHARD KAYNE & SUZANNE KAYNE LIVING TRUST DTD 01/14/1999

Document Format Files

Seq Description Document Type Size
1 SC 13G/A applied-therapeutics_sc13ga1.htm SC 13G/A 192430
  Complete submission text file 0001829126-24-001064.txt   194182
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Subject) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-91017 | Film No.: 24664189
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1900 AVENUE OF THE STARS #1000 LOS ANGELES CA 90067
Business Address 1900 AVENUE OF THE STARS #1000 LOS ANGELES CA 90067 908-507-9629
Propel Bio Management, LLC (Filed by) CIK: 0001969764 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A